America's Public Companies -DRIVING INNOVATION- Building Value
Christopher A. Dziedzic
Chris began his financial career at the Chicago Board of Trade in 1987. By 1990, he worked his way up from being a runner and into the trading pits. He traded debt instruments, eventually covering all points in the yield curve from overnight Fed Funds to the 30 year bond. In 2000, he moved across the street to the Chicago Stock Exchange where he became a specialist trading NASDAQ stocks. When the bear market began that year, Chris drew upon the trend following strategies developed in the futures market and applied them to stock investing.
He is currently President and Principal Advisor for MTS Investment Advisors, Inc. Chris founded MTS, in 2003, with two other Chicago Stock Exchange members, to manage retail accounts following their Market Trend Strategies.
Chris graduated from Chicago’s DePaul University with a degree in business administration. He holds NASD licenses for series 4, 7, 24, 63, and 65.
Chris welcomes your comments and market questions.
Watch Us! ItsAboutFinance.com is featured daily at the NASDAQ Market.
Samaritan Pharmaceuticals is a drug development company involved with innovative therapeutics' for AIDS, Alzheimer's, Cancer and Heart disease. In collaboration with Georgetown University, the company is advancing eight promising compounds.
Summit Environmental is involved in the marketing and distribution of biodegradable, non-toxic chemical products and fire suppression agents, which the patent and intellectual property rights are held by Summit.
Homeland Integrated Security Systems owns proprietary technology and has the rights to use patents to some of the most innovative and sophisticated seaport security products. Their target market is the 361 commercial seaports in the US which are vulnerable to criminal penetration.
Health Discovery Corporation is uniquely positioned in the field of pattern recognition. The company is focused on commercializing its intellectual property in genomic and proteomic biomarker discovery, medical imaging, diagnostics, and pharmaceutical advancements in personalized medicine.
